Moxydari CV 625 Tablet
Marketer
Bhandaree Consumer Products Pvt Ltd
Salt Composition
Amoxycillin (500mg) + Clavulanic Acid (125mg)
Overview Moxydari CV 625 Tablet
Amoxicillin/Clavulanate 625mg tablets combat bacterial infections by bolstering your body's defense mechanisms. This medication effectively treats infections affecting the lungs (pneumonia, for example), ears, sinuses, urinary tract, skin, and soft tissues. It's ineffective against viral illnesses like the common cold. For optimal digestive tolerance, consume this medication with food. Adhere strictly to your physician's prescribed dosage schedule, maintaining consistent intervals between doses. Regular, timed administration aids adherence. The prescribed dosage varies based on the infection; however, always complete the full course of treatment. Premature cessation allows surviving bacteria to potentially re-infect or worsen the condition. Common side effects include nausea, diarrhea, vomiting, oral/vaginal thrush, rashes, and vaginitis. While generally mild, report persistent or bothersome side effects to your doctor. Prior to commencing treatment, disclose any antibiotic allergies, kidney or liver impairments, and all other concurrent medications to your physician, as interactions may occur. This medication is generally considered safe for use during pregnancy and breastfeeding under medical supervision.
Primary Ingredients of Moxydari CV 625 Tablet
No information provided. Please provide the text you wish me to rephrase.
Uses of Moxydari CV 625 Tablet
Managing bacterial diseases
Major Benefits of Moxydari CV 625 Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Moxydari CV 625 Tablets should be administered with a meal.
Common Side effects of Moxydari CV 625 Tablet:
- Vaginal inflammation
- Mucocutaneous candidiasis
- Vomiting
- Nausea
- Diarrhea
- Skin rash
- Red spots or bumps
- Fungal infection
How to use Moxydari CV 625 Tablet:
Consume this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment period. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Moxydari CV 625 Tablets should be administered with a meal.
How Moxydari CV 625 Tablet works:
Moxydari CV 625 Tablet combines Amoxycillin, a bacterial growth inhibitor, with Clavulanic Acid, a beta-lactamase inhibitor. Amoxycillin's mechanism involves disrupting essential bacterial cell wall synthesis. Clavulanic Acid counteracts bacterial resistance mechanisms, thus bolstering Amoxycillin's effectiveness.
SAFETY ADVICE
KidneyCAUTION
Patients with kidney impairment should use Moxydari CV 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. This medication is contraindicated in individuals with severely compromised kidney function.
LiverCAUTION
Patients with hepatic impairment should use Moxydari CV 625 Tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Routine liver function testing is recommended during treatment.
What if you forget to take Moxydari CV 625 Tablet :
Should you forget a Moxydari CV 625 Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Moxydari CV 625 Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Anti-infective agents |





